HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...

In an unprecedented crisis, a small town called Taunsa Sharif, located in South Punjab, is grappling with an alarming outbreak of HIV/AIDS among minor children aged from nine months to 10 years, with ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Pepfar, a global initiative to fight HIV/Aids, has saved millions of lives since its launch in 2003. Now its future is ...